Francesc Graus Selected Research

Cyclophosphamide (Cytoxan)

1/2016	Human neurexin-3α antibodies associate with encephalitis and alter synapse development.
6/2004	Primary non-Hodgkin's lymphoma of the CNS treated with CHOD/BVAM or BVAM chemotherapy before radiotherapy: long-term survival and prognostic factors.
1/2002	Importance of radiotherapy in the outcome of patients with primary CNS lymphoma: an analysis of the CHOD/BVAM regimen followed by two different radiotherapy treatments.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Francesc Graus Research Topics

Disease

48	Encephalitis (Encephalitis, Rasmussen) 03/2024 - 08/2004
39	Neoplasms (Cancer) 01/2024 - 02/2003
21	Autoimmune Diseases of the Nervous System 12/2023 - 01/2010
18	Cerebellar Ataxia (Dysmetria) 03/2024 - 10/2008
17	Limbic Encephalitis (Paraneoplastic Limbic Encephalitis) 01/2021 - 05/2003
15	Seizures (Absence Seizure) 01/2022 - 02/2003
13	Small Cell Lung Carcinoma (Small Cell Lung Cancer) 01/2023 - 03/2003
13	Paraneoplastic Cerebellar Degeneration 01/2019 - 01/2003
11	Nervous System Diseases (Neurological Disorders) 01/2024 - 09/2012
11	Anti-N-Methyl-D-Aspartate Receptor Encephalitis 01/2023 - 02/2013
11	Neuromyelitis Optica (Devic's Disease) 01/2023 - 09/2007
11	Multiple Sclerosis 11/2021 - 03/2003
10	Opsoclonus-Myoclonus Syndrome (Kinsbourne Syndrome) 01/2021 - 03/2003
9	Stiff-Person Syndrome (Stiff Man Syndrome) 01/2023 - 05/2003
8	Brain Diseases (Brain Disorder) 12/2023 - 04/2003
8	Demyelinating Diseases (Demyelinating Disease) 01/2022 - 01/2012
8	Glioma (Gliomas) 01/2022 - 07/2005
8	Ataxia (Dyssynergia) 08/2020 - 08/2004
7	Leukocytosis (Pleocytosis) 01/2022 - 01/2013
6	Tauopathies 10/2023 - 06/2014
6	Epilepsy (Aura) 09/2021 - 11/2014
6	Neurologic Manifestations (Neurological Manifestations) 12/2020 - 02/2003
5	Myoclonus (Nocturnal Myoclonus) 01/2023 - 12/2011
5	Status Epilepticus (Complex Partial Status Epilepticus) 01/2022 - 10/2013
5	Thymoma (Thymic Carcinoma) 01/2021 - 12/2012
5	Autoimmune Diseases (Autoimmune Disease) 08/2020 - 05/2010
5	Optic Neuritis (Retrobulbar Neuritis) 01/2020 - 02/2015
5	Sleep Wake Disorders 11/2019 - 09/2014
5	Lung Neoplasms (Lung Cancer) 04/2016 - 10/2003
5	Hodgkin Disease (Hodgkin's Disease) 04/2015 - 01/2003
4	Progressive Encephalomyelitis with Rigidity 01/2023 - 12/2011
4	Temporal Lobe Epilepsy 09/2021 - 11/2014
4	Teratoma (Teratoid Tumor) 01/2020 - 12/2007
4	Cognitive Dysfunction 01/2020 - 05/2017
4	Disease Progression 01/2019 - 07/2003
4	Lambert-Eaton Myasthenic Syndrome (Lambert-Eaton Syndrome) 01/2019 - 07/2005
4	Dementia (Dementias) 01/2018 - 04/2012
4	Herpes Simplex Encephalitis (Herpes Encephalitis) 01/2018 - 07/2013
4	Parasomnias (Parasomnia) 05/2017 - 06/2014
4	Lymphoma (Lymphomas) 05/2014 - 01/2002
3	Spinal Cord Diseases 01/2023 - 12/2012
3	Movement Disorders (Movement Disorder) 01/2023 - 01/2019
3	Psychotic Disorders (Schizoaffective Disorder) 01/2022 - 01/2020
3	Cerebellar Diseases (Cerebellar Syndrome) 12/2020 - 01/2003
3	Hypoventilation 01/2019 - 10/2007
3	Paraneoplastic Polyneuropathy 05/2018 - 01/2013
3	Glioblastoma (Glioblastoma Multiforme) 11/2017 - 07/2012
3	Myelitis 03/2017 - 06/2015
3	Isaacs Syndrome (Neuromyotonia) 03/2017 - 08/2010
3	Creutzfeldt-Jakob Syndrome (Creutzfeldt-Jakob Disease) 04/2014 - 03/2002
3	Narcolepsy 03/2007 - 08/2004
2	Diplopia (Double Vision) 03/2024 - 03/2003
2	COVID-19 01/2023 - 01/2021
2	Ovarian Teratoma 01/2020 - 04/2016

Drug/Important Bio-Agent (IBA)

113	AntibodiesIBA 03/2024 - 03/2003
25	Proteins (Proteins, Gene)FDA Link 03/2024 - 01/2003
24	N-Methyl-D-Aspartate Receptors (NMDA Receptors)IBA 01/2022 - 12/2007
22	AntigensIBA 03/2024 - 01/2003
21	AutoantibodiesIBA 01/2024 - 10/2008
19	Immunoglobulin G (IgG)IBA 10/2023 - 08/2003
12	Glutamate Decarboxylase (Decarboxylase, Glutamate)IBA 03/2024 - 10/2008
10	AutoantigensIBA 10/2013 - 01/2003
8	Surface Antigens (Surface Antigen)IBA 03/2024 - 05/2012
8	Biomarkers (Surrogate Marker)IBA 01/2023 - 01/2015
8	SteroidsIBA 03/2020 - 01/2007
7	Potassium Channels (Potassium Channel)IBA 04/2017 - 01/2006
7	Voltage-Gated Potassium Channels (Voltage-Gated Potassium Channel)IBA 06/2012 - 10/2003
6	Glycine Receptors (Glycine Receptor)IBA 01/2023 - 04/2010
6	EpitopesIBA 03/2020 - 01/2003
5	Methotrexate (Mexate)FDA LinkGeneric 01/2022 - 01/2002
5	Leucine (L-Leucine)FDA Link 01/2022 - 08/2010
4	Myelin-Oligodendrocyte GlycoproteinIBA 01/2023 - 02/2015
4	Intravenous Immunoglobulins (IVIG)FDA Link 01/2018 - 04/2013
4	Membrane Proteins (Integral Membrane Proteins)IBA 01/2018 - 12/2007
3	Neurotransmitter Receptors (Neurotransmitter Receptor)IBA 01/2023 - 04/2009
3	anti-leucine-rich glioma-inactivated 1 autoantibodyIBA 01/2022 - 08/2010
3	Complement System Proteins (Complement)IBA 11/2021 - 10/2009
3	metabotropic glutamate receptor type 1IBA 12/2020 - 04/2010
3	N-Methylaspartate (NMDA)IBA 01/2019 - 01/2014
3	AMPA Receptors (AMPA Receptor)IBA 01/2019 - 04/2009
3	1,3-dipropyl-8-phenylxanthineIBA 10/2017 - 01/2013
3	Dipeptidyl-Peptidases and Tripeptidyl-PeptidasesIBA 04/2017 - 01/2013
3	Cyclophosphamide (Cytoxan)FDA LinkGeneric 01/2016 - 01/2002
3	amphiphysinIBA 10/2013 - 05/2003
3	GABA-B ReceptorsIBA 12/2012 - 01/2010
3	OrexinsIBA 03/2007 - 08/2004
3	Cytarabine (Cytosar-U)FDA LinkGeneric 06/2004 - 01/2002
2	Polytetrafluoroethylene (Teflon)FDA Link 01/2022 - 01/2021
2	Monoclonal AntibodiesIBA 01/2022 - 12/2017
2	Immunoglobulins (Immunoglobulin)IBA 11/2021 - 01/2018
2	Glutamic Acid (Glutamate)FDA Link 01/2021 - 06/2012
2	alpha- Amino- 3- hydroxy- 5- methyl- 4- isoxazolepropionic Acid (AMPA)IBA 01/2021 - 04/2010
2	AcidsIBA 01/2021 - 04/2011
2	Oligoclonal BandsIBA 08/2020 - 10/2008
2	anti-aquaporin 4 autoantibodyIBA 01/2020 - 06/2015

Therapy/Procedure

21	Therapeutics 12/2023 - 03/2003
16	Immunotherapy 01/2022 - 10/2003
9	Radiotherapy 11/2019 - 01/2002
7	Drug Therapy (Chemotherapy) 11/2019 - 06/2004
2	Kidney Transplantation 11/2021 - 02/2014